Financial News
Articles published by DiaMedica Therapeutics Inc.
![](https://mms.businesswire.com/media/20230306005174/en/1729866/22/DiaMedica-Logo-white-background.jpg)
![](https://mms.businesswire.com/media/20221109005758/en/1631268/5/DiaMedica-Logo-white-background.jpg)
DiaMedica Therapeutics Provides a Business Update and Announces Third Quarter 2022 Financial Results
November 09, 2022
Via Business Wire
Tickers
DMAC
![](https://mms.businesswire.com/media/20221107005660/en/1627444/5/DiaMedica-Logo-white-background.jpg)
DiaMedica Therapeutics to Attend the 13th Annual Craig-Hallum Alpha Select Conference November 17, 2022
November 07, 2022
Via Business Wire
Tickers
DMAC
![](https://mms.businesswire.com/media/20221031005095/en/1617980/5/DiaMedica-Logo-white-background.jpg)
DiaMedica Therapeutics to Present at Credit Suisse 31st Annual Healthcare Conference
October 31, 2022
Via Business Wire
Tickers
DMAC
![](https://mms.businesswire.com/media/20221026006012/en/1615464/5/DiaMedica-Logo-white-background.jpg)
DiaMedica Therapeutics Provides Update on ReMEDy2 Trial
October 26, 2022
Via Business Wire
Tickers
DMAC
![](https://mms.businesswire.com/media/20220914005355/en/1571281/5/DiaMedica-Logo-white-background.jpg)
DiaMedica Therapeutics Appoints Julie Daves as SVP, Clinical Development Operations
September 14, 2022
Via Business Wire
Tickers
DMAC
![](https://mms.businesswire.com/media/20220906006028/en/1562805/5/DiaMedica-Logo.jpg)
DiaMedica Therapeutics to Present at Lake Street’s 6th Annual Best Ideas Growth Conference
September 06, 2022
Via Business Wire
Tickers
DMAC
![](https://mms.businesswire.com/media/20220810005746/en/1541131/5/DiaMedica-Logo-white-background.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Via Business Wire
Tickers
DMAC
![](https://mms.businesswire.com/media/20220504005795/en/749392/5/DiaMedica-Logo-white-background.jpg)
![](https://mms.businesswire.com/media/20220428005087/en/749392/5/DiaMedica-Logo-white-background.jpg)
![](https://mms.businesswire.com/media/20220314005757/en/749392/5/DiaMedica-Logo-white-background.jpg)
![](https://mms.businesswire.com/media/20220202005261/en/749392/5/DiaMedica-Logo-white-background.jpg)
DiaMedica Therapeutics Announces Appointment of Dominic Cundari as Chief Commercial Officer
February 02, 2022
Via Business Wire
Tickers
DMAC
![](https://mms.businesswire.com/media/20220125005323/en/749392/5/DiaMedica-Logo-white-background.jpg)
Via Business Wire
Tickers
DMAC
![](https://mms.businesswire.com/media/20220105005082/en/749392/5/DiaMedica-Logo-white-background.jpg)
Via Business Wire
Tickers
DMAC
![](https://mms.businesswire.com/media/20211213005006/en/749392/5/DiaMedica-Logo-white-background.jpg)
DiaMedica Therapeutics Announces Participation in LifeSci Partners 11th Annual Corporate Access Event
December 13, 2021
Via Business Wire
Tickers
DMAC
![](https://mms.businesswire.com/media/20211117005053/en/749392/5/DiaMedica-Logo-white-background.jpg)
DiaMedica Therapeutics to Present at the Piper Sandler 33rd Annual Virtual Healthcare Conference
November 17, 2021
Via Business Wire
Tickers
DMAC
![](https://mms.businesswire.com/media/20211110006339/en/749392/5/DiaMedica-Logo-white-background.jpg)
DiaMedica Therapeutics Provides a Business Update and Announces Third Quarter 2021 Financial Results
November 10, 2021
Via Business Wire
Tickers
DMAC
![](https://mms.businesswire.com/media/20211109006141/en/749392/5/DiaMedica-Logo-white-background.jpg)
DiaMedica Therapeutics to Attend the 12th Annual Craig-Hallum Alpha Select Conference November 16, 2021
November 09, 2021
Via Business Wire
Tickers
DMAC
![](https://mms.businesswire.com/media/20211108005395/en/749392/5/DiaMedica-Logo-white-background.jpg)
![](https://mms.businesswire.com/media/20211104005276/en/749392/5/DiaMedica-Logo-white-background.jpg)
![](https://mms.businesswire.com/media/20211018005032/en/749392/5/DiaMedica-Logo-white-background.jpg)
![](https://mms.businesswire.com/media/20210930005097/en/749392/5/DiaMedica-Logo-white-background.jpg)
![](https://mms.businesswire.com/media/20210928005692/en/749392/5/DiaMedica-Logo-white-background.jpg)
DiaMedica Therapeutics Announces Closing of $30 Million Private Placement
September 28, 2021
Via Business Wire
Tickers
DMAC
![](https://mms.businesswire.com/media/20210927005199/en/749392/5/DiaMedica-Logo-white-background.jpg)
DiaMedica Therapeutics Announces $30 Million Private Placement
September 27, 2021
Via Business Wire
Tickers
DMAC
![](https://mms.businesswire.com/media/20210913005147/en/749392/5/DiaMedica-Logo-white-background.jpg)
DiaMedica Therapeutics Initiates Pivotal Trial of DM199 for the Treatment of Acute Ischemic Stroke
September 13, 2021
Via Business Wire
Tickers
DMAC
![](https://mms.businesswire.com/media/20210907005533/en/749392/5/DiaMedica-Logo-white-background.jpg)
DiaMedica Therapeutics to Participate at Upcoming Investor Conferences
September 07, 2021
Via Business Wire
Tickers
DMAC
![](https://mms.businesswire.com/media/20210811005832/en/749392/5/DiaMedica-Logo-white-background.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.